TY - JOUR
T1 - Fatal familial insomnia and familial Creutzfeldt-Jakob disease
T2 - Different prion proteins determined by a DNA polymorphism
AU - Monari, Lucia
AU - Chen, Shu G.
AU - Brown, Paul
AU - Parchi, Piero
AU - Petersen, Robert B.
AU - Mikol, Jacqueline
AU - Gray, Franscoise
AU - Cortelli, Pietro
AU - Montagna, Pasquale
AU - Ghetti, Bernardino
AU - Goldfarb, Lev G.
AU - Gajdusek, D. Carleton
AU - Lugaresi, Elio
AU - Gambetti, Pierluigi
AU - Autilio-Gambetti, Lucila
PY - 1994/3/29
Y1 - 1994/3/29
N2 - Fatal familial insomnia and a subtype of Creutzfeldt-Jakob disease, two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asp-178 → Asn) but segregate with different genotypes determined by this mutation and the methionine-valine polymorphism at codon 129 of the prion protein gene. The abnormal isoforms of the prion protein in these two diseases were found to differ both in the relative abundance of glycosylated forms and in the size of the protease-resistant fragments. The size difference was consistent with a different protease cleavage site, suggesting a different conformation of the protease-resistant prion protein present in the two diseases. These differences are likely to be responsible for the type and location of the lesions that characterize these two diseases. Therefore, the combination of the mutation at codon 178 and the polymorphism at codon 129 determines the disease phenotype by producing two altered conformations of the prion protein.
AB - Fatal familial insomnia and a subtype of Creutzfeldt-Jakob disease, two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asp-178 → Asn) but segregate with different genotypes determined by this mutation and the methionine-valine polymorphism at codon 129 of the prion protein gene. The abnormal isoforms of the prion protein in these two diseases were found to differ both in the relative abundance of glycosylated forms and in the size of the protease-resistant fragments. The size difference was consistent with a different protease cleavage site, suggesting a different conformation of the protease-resistant prion protein present in the two diseases. These differences are likely to be responsible for the type and location of the lesions that characterize these two diseases. Therefore, the combination of the mutation at codon 178 and the polymorphism at codon 129 determines the disease phenotype by producing two altered conformations of the prion protein.
UR - http://www.scopus.com/inward/record.url?scp=0028351904&partnerID=8YFLogxK
U2 - 10.1073/pnas.91.7.2839
DO - 10.1073/pnas.91.7.2839
M3 - Article
C2 - 7908444
AN - SCOPUS:0028351904
VL - 91
SP - 2839
EP - 2842
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 7
ER -